Bengaluru — Johnson & Johnson (J&J) will supply up to 220-million doses of its single-shot Covid-19 vaccine to African Union’s 55 member states from the third quarter of 2021, the drugmaker said on Monday.

J&J, through its Janssen Pharmaceutica unit, entered into a deal with the African Vaccine Acquisition Trust (Avat), which could order an additional 180-million doses, for a combined total of up to 400-million doses through 2022...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.